Date posted
Apr
6
Congress passed long-awaited legislation to reauthorize the SBIR and STTR programs, sending the bill to President Trump on April 1, 2026, for...
Read PostFederal Advocacy
Voices Heard in Washington: Federal Advocacy for Bio Community
Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.
Advocacy
Advocacy :
Federal Advocacy
Advocacy :
State Advocacy
Association Updates
BioConnections® Jobs
Event
Event :
Industry Event
Event :
MichBio Advocacy Events
Event :
MichBio Networking Event
Event :
MichBio Signature Event
Event :
MichBio Webinar
Event :
Partner Event
Member Feature
News
News :
Industry News
News :
Member News
News :
MichBio News/Statement
News :
Michigan News
Date posted
Apr
6
The White House this past week announced a sweeping new tariff policy targeting imported patented pharmaceutical products, positioning the move as...
Read Post
Date posted
Apr
6
The Trump Administration’s FY2027 budget proposal underscores a significant shift in federal priorities—pairing a record $1.5 trillion...
Read Post
Date posted
Mar
20
The future of the SBIR/STTR programs has been a critical issue for the life sciences innovation ecosystem, as highlighted in prior biolink...
Read Post
Date posted
Mar
20
The U.S. drug development landscape is entering a pivotal transition, as federal regulators and research funders accelerate efforts to reduce...
Read Post
Date posted
Mar
20
A new proposal from the U.S. Environmental Protection Agency (EPA) is reshaping the regulatory landscape for medical device sterilization -...
Read Post
Date posted
Mar
20
The FDA’s recent draft guidance clarifying the scope of 3-year New Clinical Investigation (NCI) exclusivity is more than a technical update...
Read Post
Date posted
Mar
20
A bipartisan group of lawmakers has introduced new legislation aimed at tackling a foundational challenge in AI-driven drug discovery - the lack...
Read Post
Date posted
Mar
6
After months of uncertainty for startups and technology innovators across the country, the U.S. Senate has passed bipartisan legislation, S....
Read Post
Date posted
Mar
6
The bipartisan House BIOtech Caucus recently announced its first-ever legislative endorsements, backing two bills aimed at strengthening U.S....
Read Post
Date posted
Feb
20
As Congress considers whether to codify Most Favored Nation (MFN) drug pricing into statute, recent comments by CMS Administrator Dr. Mehmet Oz...
Read Post
Date posted
Feb
20
The U.S. Food and Drug Administration (FDA) has announced a significant shift in its drug approval standards, moving away from the long-standing...
Read Post